Compass Therapeutics, Inc.·4

Feb 13, 5:09 PM ET

Anderman Jonathan 4

4 · Compass Therapeutics, Inc. · Filed Feb 13, 2025

Insider Transaction Report

Form 4
Period: 2025-02-11
Anderman Jonathan
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-11+280,000280,000 total
    Exercise: $3.65Exp: 2035-02-11Common Stock (280,000 underlying)
Footnotes (1)
  • [F1]The options vest over 48 substantially equal monthly installments starting March 11, 2025.

Documents

1 file
  • 4
    ownership.xmlPrimary